Adtalem Global Education (NYSE:CVSA) Cut to “Hold” at Truist Financial

Truist Financial downgraded shares of Adtalem Global Education (NYSE:CVSA) from a buy rating to a hold rating in a research note released on Thursday, MarketBeat reports. They currently have $140.00 price target on the stock.

Several other analysts have also recently weighed in on CVSA. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Wednesday, August 19th. Finally, Barrington Research restated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, June 8th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Adtalem Global Education presently has a consensus rating of “Hold” and a consensus target price of $155.00.

Adtalem Global Education Price Performance

CVSA opened at $128.25 on Thursday. Adtalem Global Education has a one year low of $86.97 and a one year high of $156.26. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The firm’s 50 day simple moving average is $128.24. The company has a market cap of $4.37 billion, a price-to-earnings ratio of 18.22, a price-to-earnings-growth ratio of 0.95 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, sell-side analysts expect that Adtalem Global Education will post 9 EPS for the current fiscal year.

Insider Transactions at Adtalem Global Education

In other news, CFO Robert J. Phelan sold 2,900 shares of the company’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $135.41, for a total value of $392,689.00. Following the sale, the chief financial officer directly owned 52,906 shares of the company’s stock, valued at $7,164,001.46. This represents a 5.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 3,545 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total transaction of $462,055.30. Following the completion of the transaction, the chief executive officer owned 415,197 shares of the company’s stock, valued at approximately $54,116,776.98. The trade was a 0.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 27,753 shares of company stock worth $3,717,982. Corporate insiders own 2.50% of the company’s stock.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management bought a new stake in shares of Adtalem Global Education Inc. (NYSE:CVSA) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by institutional investors and hedge funds.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.